ATC code L
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.[2]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- "ATC/DDD Index 2019: code L". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2019: code QL". WHO Collaborating Centre for Drug Statistics Methodology.
SPs/MIs (M phase) |
| ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DNA replication inhibitor |
| ||||||||||||||||||||||||||||
Photosensitizers/PDT |
| ||||||||||||||||||||||||||||
Other |
| ||||||||||||||||||||||||||||
|
Endogenous |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exogenous |
|
Intracellular (initiation) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracellular (reception) |
| ||||||||||||||
Extracellular |
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.